Nearly one year ago, Drs. Kevin Franck and Carl LeBel were on TWiH to discuss the exciting possibilities of regenerative medicine in hearing and the incredible progress, Frequency Therapeutics, has made on understanding the potential of applying it to clinical practice.
This week they joined Brian Taylor to update us on two clinical trials and how the results of these two trials could expand the scope of hearing restoration in the future.
Be sure to subscribe to our KZitem channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter:
/ this-week-in-hearing
/ weekinhearing
TIMESTAMPS
00:00 Background
00:41 Latest FX-322 Clinical Trial
05:25 Study Design
08:50 FX-322 Phase 2B Clinical Trial
10:00 New FX-345 Clinical Trial
12:40 Benefit to Patients with Hearing Loss
16:25 New Patient Outcome Measure Developed
Негізгі бет Ғылым және технология Regenerative Medicine and Hearing Restoration: Update on Frequency Therapeutics Clinical Trials
Пікірлер: 6